Applied DNA Sciences (NASDAQ:APDN) Issues Quarterly Earnings Results

Applied DNA Sciences (NASDAQ:APDN) posted its earnings results on Thursday. The technology company reported $0.47 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.64) by $1.11, Zacks reports. Applied DNA Sciences had a negative return on equity of 306.32% and a negative net margin of 222.33%. The company had revenue of $0.80 million for the quarter, compared to analyst estimates of $0.95 million. During the same quarter in the previous year, the firm earned ($4.80) earnings per share.

Applied DNA Sciences Trading Up 2.9 %

Shares of APDN stock traded up $0.01 during trading hours on Friday, reaching $0.36. 424,759 shares of the company’s stock were exchanged, compared to its average volume of 492,432. The stock’s fifty day moving average price is $0.44 and its two-hundred day moving average price is $5.39. The stock has a market cap of $354,600.00, a PE ratio of -0.02 and a beta of 0.09. Applied DNA Sciences has a 1 year low of $0.33 and a 1 year high of $35.90.

Analyst Upgrades and Downgrades

APDN has been the topic of a number of research analyst reports. HC Wainwright dropped their price target on Applied DNA Sciences from $7.00 to $1.50 and set a “buy” rating on the stock in a research note on Monday, June 10th. StockNews.com initiated coverage on Applied DNA Sciences in a research note on Thursday. They set a “sell” rating on the stock.

Applied DNA Sciences Company Profile

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.